These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FES, FPS, 2242, ENSG00000182511, P07332 AND Treatment
20 results:

  • 1. Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study).
    Kinos S; Hagman H; Halonen P; Soveri LM; O'Reilly M; Pfeiffer P; Frödin JE; Sorbye H; Heervä E; Liposits G; Kallio R; Ålgars A; Ristamäki R; Salminen T; Bärlund M; Shah CH; McDermott R; Röckert R; Flygare P; Kwakman J; Teske A; Punt C; Glimelius B; Österlund P
    Acta Oncol; 2024 May; 63():248-258. PubMed ID: 38698698
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
    Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
    J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ColonNet: A novel polyp segmentation framework based on LK-RFB and GPPD.
    Sui D; Liu W; Zhang Y; Li Y; Luo G; Wang K; Guo M
    Comput Biol Med; 2023 Nov; 166():107541. PubMed ID: 37804779
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition.
    Kawasaki Y; Kakimoto K; Tanaka Y; Shimizu H; Nishida K; Numa K; Kinoshita N; Tatsumi Y; Nakazawa K; Koshiba R; Hirata Y; Ota K; Sakiyama N; Terazawa T; Takeuchi T; Miyazaki T; Goto M; Yokota H; Makizaki Y; Tanaka Y; Nakajima S; Ohno H; Higuchi K; Nakamura S; Nishikawa H
    Digestion; 2023; 104(5):357-369. PubMed ID: 37231829
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer.
    Punt CJA; Heinemann V; Maughan T; Cremolini C; Van Cutsem E; McDermott R; Bodoky G; André T; Osterlund P; Teske AJ; Pfeiffer P
    ESMO Open; 2023 Apr; 8(2):101199. PubMed ID: 37018874
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Precision fluoropyrimidines dosing in a compound heterozygous variant carrier of the DPYD gene: a case report.
    Baiardi G; Clavarezza M; Stella M; Casazza S; De Censi A; Mattioli F
    Cancer Chemother Pharmacol; 2023 May; 91(5):435-439. PubMed ID: 36890284
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis.
    Lin JF; Hu PS; Wang YY; Tan YT; Yu K; Liao K; Wu QN; Li T; Meng Q; Lin JZ; Liu ZX; Pu HY; Ju HQ; Xu RH; Qiu MZ
    Signal Transduct Target Ther; 2022 Feb; 7(1):54. PubMed ID: 35221331
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fermentation profile, cholesterol-reducing properties and chemopreventive potential of β-glucans from
    Schlörmann W; Bockwoldt JA; Mayr MF; Lorkowski S; Dawczynski C; Rohn S; Ehrmann MA; Glei M
    Food Funct; 2021 Nov; 12(21):10615-10631. PubMed ID: 34585204
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. How I treat stage II colon cancer patients.
    Taieb J; Karoui M; Basile D
    ESMO Open; 2021 Aug; 6(4):100184. PubMed ID: 34237612
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Persistent High Rate of Positive Margins and Postoperative Complications After Surgery for cT4 Rectal cancer at a National Level.
    de Nes LCF; Drager LD; Verstegen MG; Burger JWA; Tanis PJ; de Wilt JHW;
    Dis Colon Rectum; 2021 Apr; 64(4):389-398. PubMed ID: 33651005
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chemistry of Fluorinated Pyrimidines in the Era of Personalized Medicine.
    Gmeiner WH
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751071
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience.
    Khan K; Rane JK; Cunningham D; Rao S; Watkins D; Starling N; Kalaitzaki E; Forster M; Braconi C; Valeri N; Gerlinger M; Chau I
    Clin Colorectal Cancer; 2019 Mar; 18(1):64-71.e1. PubMed ID: 30404764
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
    Canal F; Anthony E; Lescure A; Del Nery E; Camonis J; Perez F; Ragazzon B; Perret C
    BMC Cancer; 2015 Dec; 15():1020. PubMed ID: 26715116
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Current applications of PET imaging of sex hormone receptors with a fluorinated analogue of estradiol or of testosterone.
    Talbot JN; Gligorov J; Nataf V; Montravers F; Huchet V; Michaud L; Ohnona J; Balogova S; Cussenot O; Daraï E; Lotz JP; Kerrou K
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):4-17. PubMed ID: 25693420
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Influence of dihydropyrimidine dehydrogenase gene (DPYD) coding sequence variants on the development of fluoropyrimidine-related toxicity in patients with high-grade toxicity and patients with excellent tolerance of fluoropyrimidine-based chemotherapy.
    Kleibl Z; Fidlerova J; Kleiblova P; Kormunda S; Bilek M; Bouskova K; Sevcik J; Novotny J
    Neoplasma; 2009; 56(4):303-16. PubMed ID: 19473056
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Promoter methylation blocks fes protein-tyrosine kinase gene expression in colorectal cancer.
    Shaffer JM; Smithgall TE
    Genes Chromosomes Cancer; 2009 Mar; 48(3):272-84. PubMed ID: 19051325
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The effects of quercetin on SW480 human colon carcinoma cells: a proteomic study.
    Mouat MF; Kolli K; Orlando R; Hargrove JL; Grider A
    Nutr J; 2005 Mar; 4():11. PubMed ID: 15748282
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Family physicians' perspectives on practice guidelines related to cancer control.
    Zitzelsberger L; Grunfeld E; Graham ID
    BMC Fam Pract; 2004 Nov; 5():25. PubMed ID: 15544701
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts.
    Liu C; Willingham M; Liu J; Gmeiner WH
    Int J Oncol; 2002 Aug; 21(2):303-8. PubMed ID: 12118325
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Phase II study of the water-soluble nitrosourea compound ACNU in advanced colorectal carcinomas].
    Fiebig HH; Wellens W; Peukert M; Henss H; Arnold H; Westerhausen M; Löhr GW
    Onkologie; 1984 Dec; 7(6):370-7. PubMed ID: 6396565
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.